The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 7390-7399
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ahrens, R.
Right arrow Articles by Hogan, S. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ahrens, R.
Right arrow Articles by Hogan, S. P.

Intestinal Macrophage/Epithelial Cell-Derived CCL11/Eotaxin-1 Mediates Eosinophil Recruitment and Function in Pediatric Ulcerative Colitis1

Richard Ahrens*, Amanda Waddell*, Luqman Seidu*, Carine Blanchard*, Rebecca Carey{dagger}, Elizabeth Forbes*, Maria Lampinen||, Tara Wilson{dagger}, Elizabeth Cohen*, Keith Stringer{ddagger}, Edgar Ballard{ddagger}, Ariel Munitz*, Huan Xu§, Nancy Lee, James J. Lee, Marc E. Rothenberg*, Lee Denson{dagger} and Simon P. Hogan2,*

* Division of Allergy and Immunology, {dagger} Division of Gastroenterology, Hepatology and Nutrition, {ddagger} Division of Pathology, and § Division of Biomedical Informatics, Department of Pediatrics, University of Cincinnati College of Medicine, CCHMC, Cincinnati, OH 45229; Division of Pulmonary Medicine, Mayo Clinic Arizona, Scottsdale, AZ 85259; || Department of Medical Sciences, University of Uppsala, Uppsala, Sweden

Clinical studies have demonstrated a link between the eosinophil-selective chemokines, eotaxins (eotaxin-1/CCL11 and eotaxin-2/CCL24), eosinophils, and the inflammatory bowel diseases, Crohn’s disease and ulcerative colitis (UC). However, the cellular source and individual contribution of the eotaxins to colonic eosinophilic accumulation in inflammatory bowel diseases remain unclear. In this study we demonstrate, by gene array and quantitative PCR, elevated levels of eotaxin-1 mRNA in the rectosigmoid colon of pediatric UC patients. We show that elevated levels of eotaxin-1 mRNA positively correlated with rectosigmoid eosinophil numbers. Further, colonic eosinophils appeared to be degranulating, and the levels positively correlated with disease severity. Using the dextran sodium sulfate (DSS)-induced intestinal epithelial injury model, we show that DSS treatment of mice strongly induced colonic eotaxin-1 and eotaxin-2 expression and eosinophil levels. Analysis of eosinophil-deficient mice defined an effector role for eosinophils in disease pathology. DSS treatment of eotaxin-2–/– and eotaxin-1/2–/– mice demonstrated that eosinophil recruitment was dependent on eotaxin-1. In situ and immunofluorescence analysis-identified eotaxin-1 expression was restricted to intestinal F4/80+CD11b+ macrophages in DSS-induced epithelial injury and to CD68+ intestinal macrophages and the basolateral compartment of intestinal epithelial cells in pediatric UC. These data demonstrate that intestinal macrophage and epithelial cell-derived eotaxin-1 plays a critical role in the regulation of eosinophil recruitment in colonic eosinophilic disease such as pediatric UC and provides a basis for targeting the eosinophil/eotaxin-1 axis in UC.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported in part by Crohn’s Colitis Foundation of American Career Development Award 2007 (to S.P.H.), Digestive Disease Health Center Pilot and Feasibility Research Grant of the National Institutes of Health-supported Cincinnati Children’s Hospital Research Foundation Digestive Health Center (1P30DK078392-01) (to S.P.H.), and National Institutes of Health Grant R01 DK058259 (to L.D.).

2 Address correspondence and reprint requests to Dr. Simon P. Hogan, Division of Allergy and Immunology, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Avenue, ML7028, Cincinnati OH 45229. E-mail address: simon.hogan{at}cchmc.org

3 Abbreviations used in this paper: IBD, Inflammatory bowel disease; CD, Crohn’s disease; DSS, dextran sodium sulphate; EPO, eosinophil peroxidase; GI, gastrointestinal; hpf, high-powered field; UC, ulcerative colitis; UCHIS, UC histologic index of severity; WT, wild type.

4 The online version of this article contains supplemental material.




This article has been cited by other articles:


Home page
J. Immunol.Home page
A. Munitz, L. Seidu, E. T. Cole, R. Ahrens, S. P. Hogan, and M. E. Rothenberg
Resistin-Like Molecule {alpha} Decreases Glucose Tolerance during Intestinal Inflammation
J. Immunol., February 15, 2009; 182(4): 2357 - 2363.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.